Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cross Country Healthcare (CCRN – Research Report), Castle Biosciences (CSTL – Research Report) and Andlauer Healthcare Group (ANDHF – Research Report).
Cross Country Healthcare (CCRN)
In a report released today, Kevin Steinke from Barrington maintained a Buy rating on Cross Country Healthcare, with a price target of $21.00. The company’s shares closed last Friday at $16.67, close to its 52-week low of $15.65.
According to TipRanks.com, Steinke is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Cross Country Healthcare with a $18.67 average price target, a 10.5% upside from current levels. In a report issued on May 2, Benchmark Co. also reiterated a Buy rating on the stock with a $19.00 price target.
See today’s best-performing stocks on TipRanks >>
Castle Biosciences (CSTL)
In a report released today, Sung Ji Nam from Scotiabank maintained a Buy rating on Castle Biosciences, with a price target of $37.00. The company’s shares closed last Friday at $24.33, close to its 52-week high of $26.70.
According to TipRanks.com, Nam ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Castle Biosciences with a $33.83 average price target, a 44.0% upside from current levels. In a report issued on May 3, Robert W. Baird also maintained a Buy rating on the stock with a $34.00 price target.
Andlauer Healthcare Group (ANDHF)
In a report released today, Konark Gupta from Scotiabank maintained a Hold rating on Andlauer Healthcare Group, with a price target of C$46.00. The company’s shares closed last Friday at $37.80.
According to TipRanks.com, Gupta is a 5-star analyst with an average return of
Currently, the analyst consensus on Andlauer Healthcare Group is a Moderate Buy with an average price target of $36.76.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CCRN:
- Cross Country Healthcare Issues Informative Press Statement
- Cross Country Healthcare Issues Insightful Press Statement
- Cross Country Healthcare sees Q2 adjusted EPS 10c-20c, consensus 18c
- Cross Country Healthcare reports Q1 adjusted EPS 19c, consensus 17c
- CCRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?